1. Home
  2. LRMR vs BKSY Comparison

LRMR vs BKSY Comparison

Compare LRMR & BKSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LRMR
  • BKSY
  • Stock Information
  • Founded
  • LRMR N/A
  • BKSY 2013
  • Country
  • LRMR United States
  • BKSY United States
  • Employees
  • LRMR N/A
  • BKSY N/A
  • Industry
  • LRMR Biotechnology: Pharmaceutical Preparations
  • BKSY Radio And Television Broadcasting And Communications Equipment
  • Sector
  • LRMR Health Care
  • BKSY Technology
  • Exchange
  • LRMR Nasdaq
  • BKSY Nasdaq
  • Market Cap
  • LRMR 171.6M
  • BKSY 157.7M
  • IPO Year
  • LRMR N/A
  • BKSY N/A
  • Fundamental
  • Price
  • LRMR $2.67
  • BKSY $14.21
  • Analyst Decision
  • LRMR Strong Buy
  • BKSY Strong Buy
  • Analyst Count
  • LRMR 7
  • BKSY 6
  • Target Price
  • LRMR $18.86
  • BKSY $20.33
  • AVG Volume (30 Days)
  • LRMR 1.1M
  • BKSY 1.4M
  • Earning Date
  • LRMR 08-06-2025
  • BKSY 08-07-2025
  • Dividend Yield
  • LRMR N/A
  • BKSY N/A
  • EPS Growth
  • LRMR N/A
  • BKSY N/A
  • EPS
  • LRMR N/A
  • BKSY N/A
  • Revenue
  • LRMR N/A
  • BKSY $107,401,000.00
  • Revenue This Year
  • LRMR N/A
  • BKSY $31.61
  • Revenue Next Year
  • LRMR N/A
  • BKSY $27.90
  • P/E Ratio
  • LRMR N/A
  • BKSY N/A
  • Revenue Growth
  • LRMR N/A
  • BKSY 7.05
  • 52 Week Low
  • LRMR $1.61
  • BKSY $3.86
  • 52 Week High
  • LRMR $11.20
  • BKSY $21.92
  • Technical
  • Relative Strength Index (RSI)
  • LRMR 56.20
  • BKSY 69.62
  • Support Level
  • LRMR $2.60
  • BKSY $10.80
  • Resistance Level
  • LRMR $3.02
  • BKSY $13.34
  • Average True Range (ATR)
  • LRMR 0.25
  • BKSY 0.90
  • MACD
  • LRMR 0.01
  • BKSY 0.06
  • Stochastic Oscillator
  • LRMR 51.35
  • BKSY 87.48

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

About BKSY BlackSky Technology Inc.

BlackSky Technology Inc is a provider of real-time geospatial intelligence. The company delivers on-demand, high-frequency imagery, monitoring, and analytics of some of the critical and strategic locations, economic assets, and events in the world. It designs, owns, and operates one of the industry's low earth orbit (LEO) small satellite constellations, optimized to capture imagery cost-efficiently where and when its customers need it. its Spectra AI software platform processes data from BlackSky's constellation and from other third-party sensors to develop the critical insights and analytics that provide its customers with the actionable intelligence. Geographically, the company operates in North America, the Middle East, Asia, and Others.

Share on Social Networks: